The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.
The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.
复制标题
核因子-kappaB通路在重症新冠肺炎患者中的作用及治疗潜力
DOI:
10.1007/s10787-020-00773-9
复制
发表时间:
2021-03
影响因子:
5.8
通讯作者:
Rela M
中科院分区:
文献类型:
--
作者:
Hariharan A;Hakeem AR;Radhakrishnan S;Reddy MS;Rela M
Coronavirus disease 2019 (COVID-19) pandemic has affected health care systems worldwide. Severe presentations of COVID-19 such as severe pneumonia and acute respiratory distress syndrome (ARDS) have been associated with the post-viral activation and release of cytokine/chemokines which leads to a “cytokine storm” causing inflammatory response and destruction, mainly affecting the lungs. COVID-19 activation of transcription factor, NF-kappa B (NF-κB) in various cells such as macrophages of lung, liver, kidney, central nervous system, gastrointestinal system and cardiovascular system leads to production of IL-1, IL-2, IL-6, IL-12, TNF-α, LT-α, LT-β, GM-CSF, and various chemokines. The sensitised NF-κB in elderly and in patients with metabolic syndrome makes this set of population susceptible to COVID-19 and their worse complications, including higher mortality. Immunomodulation at the level of NF-κB activation and inhibitors of NF-κB (IκB) degradation along with TNF-α inhibition will potentially result in a reduction in the cytokine storm and alleviate the severity of COVID-19. Inhibition of NF-κB pathway has a potential therapeutic role in alleviating the severe form of COVID-19.
登录
查看更多内容
DOI:
10.1038/nrmicro.2016.81
发表时间:
2016-08
期刊:
Nature reviews. Microbiology
影响因子:
--
作者:
de Wit E;van Doremalen N;Falzarano D;Munster VJ
通讯作者:
Munster VJ
影响因子:
29
作者:
Baker RG;Hayden MS;Ghosh S
通讯作者:
Ghosh S
影响因子:
9
作者:
Channappanavar R;Perlman S
通讯作者:
Perlman S
影响因子:
11.2
作者:
Cao, Yuan;Slaney, Clare Y.;Anderson, Robin L.
通讯作者:
Anderson, Robin L.
影响因子:
56.9
作者:
AUPHAN, N;DIDONATO, JA;KARIN, M
通讯作者:
KARIN, M